Related Experiment Video

Updated: Oct 29, 2025

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery
13:19

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Published on: April 26, 2024

3.1K

Antibody-Drug Conjugates Used in Breast Cancers

Aram J Abbas1, Marah F Ibrahim2, Maher S Saifo1,2

  • 1Faculty of Medicine, Damascus University, Damascus, Syria.

Journal of Oncology
|July 14, 2021
PubMed

Insights

Recent advances in breast cancer treatment have led to improved patient outcomes. Novel antibody-drug conjugates (ADCs) represent a promising targeted therapy strategy for controlling breast cancer progression.

Area of Science:

  • Oncology
  • Pharmacology
  • Biotechnology

Background:

  • Breast cancer prognosis has significantly improved due to effective therapies.
  • Targeted drug delivery systems are emerging as key advancements.

Purpose of the Study:

  • To summarize recent publications on novel antibody-drug conjugates (ADCs).
  • To highlight the development of ADCs for breast cancer control.

Main Methods:

  • Review of recent scientific literature.
  • Analysis of novel antibody-drug conjugate developments.

Main Results:

  • Effective therapies have improved breast cancer outcomes.
  • New targeted strategies, including ADCs, are being developed.

Conclusions:

  • Antibody-drug conjugates show promise in controlling breast cancer.
  • Continued development of ADCs is crucial for advancing breast cancer treatment.

More Related Videos

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting11:58

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting

Published on: March 8, 2018

7.8K
Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction11:02

Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction

Published on: September 14, 2018

7.9K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.0K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.3K